Stocks · News reference

Regentis Biomaterials Shares Halted On Circuit Breaker To The Upside, Stock now Up 787.33%

Jun 15, 2026, 5:53 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaJul 20, 2026, 1:03 PMBenzinga Newsdesk
Regentis Gets Japan Patent Office Notice of Allowance For Organic Solvent‑Free Protein‑Polymer Conjugate Compositions, Covering GelrinC Manufacturing Process And Ready‑to‑Use Liquid Formulation for Articular Cartilage Repair
Patent expands intellectual property protection in one of the world's largest cartilage repair marketsGelrinC is a cell-free hydrogel delivered in a single ~10-minute procedure eliminating the need for cell
Read original at benzinga
RGNT
BenzingaJul 15, 2026, 1:02 PMBenzinga Newsdesk
Regentis Biomaterials Receives European Regulatory Approval For New GelrinC Manufacturing Process
The approval comes as Regentis prepares for the commercial launch of GelrinC® in Europe, enabling the Company to manufacture commercial product using a process that increases production yield by approximately 400%,
Read original at benzinga
RGNT
BenzingaJun 17, 2026, 2:40 PMKaustubh Bagalkote
Why Is Regentis Biomaterials Stock Rising On Wednesday?
Regentis Biomaterials Ltd. (RGNT) stock rises after withdrawing its Form F-1 registration statement and accelerating European commercialization for GelrinC.
Read original at benzinga
RGNT